Telomere fusion threshold identifies a poor prognostic subset of breast cancer patients.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 4449122)

Published in Mol Oncol on February 25, 2015

Authors

K Simpson1, R E Jones1, J W Grimstead1, R Hills1, C Pepper1, D M Baird2

Author Affiliations

1: Institute of Cancer & Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK.
2: Institute of Cancer & Genetics, School of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK. Electronic address: bairddm@cardiff.ac.uk.

Articles cited by this

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature (2012) 20.47

Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev (2005) 15.19

Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J (1992) 10.97

PARP inhibition: PARP1 and beyond. Nat Rev Cancer (2010) 6.70

Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res (2009) 5.68

In situ analyses of genome instability in breast cancer. Nat Genet (2004) 4.32

Extensive allelic variation and ultrashort telomeres in senescent human cells. Nat Genet (2003) 3.77

Telomere length abnormalities occur early in the initiation of epithelial carcinogenesis. Clin Cancer Res (2004) 2.84

DNA ligase III promotes alternative nonhomologous end-joining during chromosomal translocation formation. PLoS Genet (2011) 2.22

Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study. Lancet Oncol (2009) 2.17

Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis. Blood (2010) 2.16

The nature of telomere fusion and a definition of the critical telomere length in human cells. Genes Dev (2007) 1.88

The function of classical and alternative non-homologous end-joining pathways in the fusion of dysfunctional telomeres. EMBO J (2010) 1.83

Telomerase activity in human breast tumors. J Natl Cancer Inst (1996) 1.73

Telomere shortening occurs in subsets of normal breast epithelium as well as in situ and invasive carcinoma. Am J Pathol (2004) 1.44

Genomic instability in breast cancer: pathogenesis and clinical implications. Mol Oncol (2010) 1.43

Telomere shortening occurs early during breast tumorigenesis: a cause of chromosome destabilization underlying malignant transformation? J Mammary Gland Biol Neoplasia (2004) 1.38

Rational design of human DNA ligase inhibitors that target cellular DNA replication and repair. Cancer Res (2008) 1.36

Robust chromosomal DNA repair via alternative end-joining in the absence of X-ray repair cross-complementing protein 1 (XRCC1). Proc Natl Acad Sci U S A (2012) 1.31

Telomere content correlates with stage and prognosis in breast cancer. Breast Cancer Res Treat (2006) 1.27

Telomere length as a biological marker in malignancy. Biochim Biophys Acta (2009) 1.19

Fusion of short telomeres in human cells is characterized by extensive deletion and microhomology, and can result in complex rearrangements. Nucleic Acids Res (2009) 1.19

Utilizing prognostic and predictive factors in breast cancer. Curr Treat Options Oncol (2005) 1.12

Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage disease. Br J Haematol (2014) 1.07

Reduction of telomeric length and c-erbB-2 gene amplification in human breast cancer, fibroadenoma, and gynecomastia. Relationship to histologic grade and clinical parameters. Cancer (1994) 0.99

Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome. Breast Cancer Res (2011) 0.98

Extensive telomere erosion in the initiation of colorectal adenomas and its association with chromosomal instability. J Natl Cancer Inst (2013) 0.98

Telomere fusions in early human breast carcinoma. Proc Natl Acad Sci U S A (2012) 0.97

Telomere DNA content predicts breast cancer-free survival interval. Clin Cancer Res (2007) 0.91

Mre11 modulates the fidelity of fusion between short telomeres in human cells. Nucleic Acids Res (2011) 0.86

The relationship between telomere length and telomerase activity in gynecologic cancers. Gynecol Oncol (2002) 0.84

Detection of telomerase activity in breast masses by fine-needle aspiration. Ann Surg Oncol (1998) 0.81

Short telomeres are frequent in hereditary breast tumors and are associated with high tumor grade. Breast Cancer Res Treat (2013) 0.80